What 192 Patients Reveal About Precision AML Care in Kuwait / Acute Myeloid Leukemia, Ahmad Alhuraiji, Allogeneic HSCT, AML, ...

SEATTLE, WA / ACCESS Newswire / October 26, 2026 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology ...

A new review maps how FLT3 inhibitors became standard therapy across newly diagnosed and relapsed AML while trials test ...

Retail bulls discussed buying the dip and a potential buyout, while others also challenged survival estimates.

Dr. Mahmoudjafari asks Dr. Murthy how he weighs frailty, comorbidities, and functional status when choosing initial treatment ...

Austrian and Dutch forecasts point to potential GPS approval or registration in November and August 2027, respectively.

High CD84 expression correlates with venetoclax resistance in AML, and targeting the CD84-SESN2 pathway sensitized leukemia ...

AcTor was combined with ixazomib (IXZ), a drug used to inhibit cancer cell proliferation. Together, the treatments disrupt ...

Panelists discuss how the pathophysiology of acute myeloid leukemia has evolved from a single phenotype understanding to recognizing diverse genetic events that lead to transformation at the ...

The first patient was dosed in an early U.S. clinical trial testing a new infusion therapy for people with ...

Explore the global AML pipeline, emerging therapies, clinical stages, mechanisms, collaborations, licensing, unmet needs and inactive candidatesDublin, Oct. (GLOBE NEWSWIRE) -- "Acute Myeloid Leukemia ...

A father of three thought his knee pain had a benign cause. Doctors found advanced, treatment-resistant cancer.